December 20, 2024

POI Guidelines See First Major Update Since 2015

Four medical societies have revised their diagnostic criteria for premature ovarian insufficiency, now requiring only one elevated FSH test instead of two, while reporting a higher than previously known prevalence rate of 3.5% among women.

Conexiant

December 18, 2024

USPSTF Challenges Common Supplement Use

"Unfortunately, when we reviewed the latest evidence, we found that taking vitamin D with or without calcium does not prevent falls or fractures in older adults."

Conexiant

December 17, 2024

AHA Updates Stroke Palliative Care Guidelines

Updated statement promotes integrated palliative care for all stroke patients.

Conexiant

December 16, 2024

New Four-Stage System Redefines AF Care

New atrial fibrillation management guidelines embrace a novel 4-stage classification system and early rhythm control strategy, with clinical trials showing a 21% reduction in cardiovascular outcomes when rhythm control is initiated within 12 months of diagnosis.

Conexiant

December 16, 2024

New Guidelines Address Elder Surgery Care

Expanded preoperative evaluations can reduce postoperative delirium by 23% in older adults, but frailty doubles the risk—are your patients screened effectively?

Conexiant

December 09, 2024

ADA Guidelines Add Tech Focus for Diabetes Care

The 2025 Standards introduce continuous glucose monitoring recommendations for type 2 diabetes patients not on insulin therapy, while new guidance addresses religious fasting, automated insulin delivery in pregnancy, and specific blood glucose targets for hospitalized patients.

Conexiant

December 09, 2024

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

After the positive results of the monarchE and NATALEE trials, the necessity of neoadjuvant chemotherapy is being questioned in HR-positive, HER2-negative early breast cancer. Kazuki Nozawa, MD, of Na...

The ASCO Post

December 06, 2024

Experts Set First Global CNO Treatment Guidelines

An international expert panel introduces the first consensus recommendations for diagnosing and treating chronic non-bacterial osteitis (CNO) in adults - consolidating multiple disease labels into a single entity and establishing evidence-based protocols.

Conexiant

December 05, 2024

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

On December 4, 2024, the U.S. Food and Drug Administration approved durvalumab (Imfinzi) for adults with limited-stage small cell lung cancer (SCLC) whose disease has not progressed following concurre...

The ASCO Post